[The efficacy and safety of Bruton tyrosine kinase inhibitors as monotherapy in the treatment of newly diagnosed patients with Waldenström macroglobulinemia].
Zhonghua Xue Ye Xue Za Zhi
; 44(6): 490-494, 2023 Jun 14.
Article
in Zh
| MEDLINE
| ID: mdl-37550205
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Waldenstrom Macroglobulinemia
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
China